- Home
- RLI vs HALO Comparison
RLI vs HALO Comparison
Compare RLI & HALO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RLI
- HALO
- Stock Information
- Founded
- RLI 1965
- HALO 1998
- Country
- RLI United States
- HALO United States
- Employees
- RLI N/A
- HALO N/A
- Industry
- RLI Property-Casualty Insurers
- HALO Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- RLI Finance
- HALO Health Care
- Exchange
- RLI Nasdaq
- HALO Nasdaq
- Market Cap
- RLI 7.1B
- HALO 7.4B
- IPO Year
- RLI 1985
- HALO N/A
- Fundamental
- Price
- RLI $73.01
- HALO $60.67
- Analyst Decision
- RLI Hold
- HALO Buy
- Analyst Count
- RLI 8
- HALO 9
- Target Price
- RLI $78.60
- HALO $62.89
- AVG Volume (30 Days)
- RLI 491.1K
- HALO 1.6M
- Earning Date
- RLI 04-23-2025
- HALO 05-06-2025
- Dividend Yield
- RLI 6.88%
- HALO N/A
- EPS Growth
- RLI N/A
- HALO 63.33
- EPS
- RLI 3.03
- HALO 3.43
- Revenue
- RLI $1,733,218,000.00
- HALO $1,015,324,000.00
- Revenue This Year
- RLI N/A
- HALO $20.06
- Revenue Next Year
- RLI $4.70
- HALO $24.20
- P/E Ratio
- RLI $24.08
- HALO $17.61
- Revenue Growth
- RLI 8.88
- HALO 22.44
- 52 Week Low
- RLI $68.50
- HALO $37.97
- 52 Week High
- RLI $91.15
- HALO $66.00
- Technical
- Relative Strength Index (RSI)
- RLI 38.83
- HALO 45.20
- Support Level
- RLI $74.49
- HALO $56.47
- Resistance Level
- RLI $79.55
- HALO $59.39
- Average True Range (ATR)
- RLI 2.77
- HALO 2.75
- MACD
- RLI -0.34
- HALO -0.22
- Stochastic Oscillator
- RLI 17.63
- HALO 45.10
About RLI RLI Corp. (DE)
RLI Corp underwrites property and casualty insurance through its subsidiaries. The company offers insurance coverage in the specialty admitted market, where the products are designed for special risks. It also offers products in the excess and surplus markets, which provides an alternative for customers with risks or loss exposures that generally cannot be written in the standard admitted market. RLI distributes property and casualty insurance through its wholly-owned branch offices that market to wholesale and retail producers. The company's insurance operation segments include Casualty, Property, and Surety and it derives a majority of its revenue from the Casualty segment.
About HALO Halozyme Therapeutics Inc.
Halozyme Therapeutics Inc is a biotechnology company focused on developing and commercializing novel oncology therapies. The company seeks to create therapies focused on human enzymes that alter tumors. Halozyme focuses on developing its proprietary products in therapeutic areas with a focus on oncology, and licensing its technology to biopharmaceutical companies to collaboratively develop products. The company's operations are based in the United States, with minimal long-lived assets located internationally.